Major Depressive Disorder - US Drug Forecast and Market Assessment to 2025

Market: Pharmaceuticals and Healthcare

United States, 326 pages report, published by GlobalData

Report ThumbnailOctober-2016
Major Depressive Disorder - US Drug Forecast and Market Assessment to 2025

Summary

Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized by single or recurrent major depressive episodes (MDEs), where patients can typically experience periods of depressed mood, loss of energy, abnormal cognition, anxiety and suicidal ideation. Similar to other neuropsychiatric disorders, MDD has a multifaceted and varied etiology, and remains poorly unders

Read More
  • 1.2 List of Figures
  • Figure 1: Overview of Targets of Antidepressant Action on Noradrenergic and Serotonergic Neurons 17
  • Figure 2: Disease Management Model for Major Depressive Disorder 25
  • Figure 3: Major Depressive Disorder Treatment Algorithm 27
  • Figure 4: MDD Therapeutics - Phase II and III Clinical Trials in the 7MM, 2016 167
  • Figure 5: MDD Phase II/Phase III Pipeline, 2016 169
  • Figure 6: Competitive Assessment of Late-Stage Pipeline Agents in MDD, 2015-2025 171
  • Figure 7: Clinical and Commercial
Read More
  • 1.1 List of Tables
  • Table 1: Classification and Criteria of MDD (DSM-IV) and MDE (ICD-10) 18
  • Table 2: Subtypes of Major Depressive Disorder 19
  • Table 3: Severity of Depressive Episodes According to ICD-10 and DSM-IV Diagnostic Criteria 22
  • Table 4: Treatment Guidelines for Major Depressive Disorder 23
  • Table 5: Most-Prescribed Drugs for MDD by Class in the 7MM, 2015 24
  • Table 6: Country Profile - US 30
  • Table 7: Leading Treatments for MDD, 2016 33
  • Table 8: Product Profile - Lexapro 37
  • Table 9: Lexapro
Read More
  • 1 Table of Contents
  • 1 Table of Contents 2
  • 1.1 List of Tables 6
  • 1.2 List of Figures 10
  • 2 Introduction 11
  • 2.1 Related Reports 11
  • 2.2 Upcoming Related Reports 12
  • 3 Disease Overview 13
  • 3.1 Etiology and Pathophysiology 13
  • 3.1.1 Etiology 13
  • 3.1.2 Pathophysiology 14
  • 3.2 Classification 17
  • 3.3 Symptoms and Subtypes of Major Depressive Disorder 19
  • 3.4 Prognosis 20
  • 3.5 Quality of Life 20
  • 4 Disease Management 21
  • 4.1 Diagnosis and Treatment Overview 21
  • 4.1.1 Diagnosis 21
  • 4.1.2 Treatment Guidelines 22
  • 4.1.3 C
Read More

Please select a license type

Share

Related Products

GlobalDataMajor Depressive Disorder - US Drug Forecast and Market Assessment to 2025Product ThumbnailMajor Depressive Disorder - US Drug Forecast and Market Assessment to 2025, Industry ReportProduct #: 631515
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved